Home
CellSource

CellSource Market Share Analysis for February 2026

セルソースは、再生医療のプラットフォームとして、法規対応支援、医療機関・研究機関と連携した新治療の開発、加工受託までを提供しています。

Finance > Investing

Domaincellsource.co.jp

Year Founded2015

Employees51 - 200

Annual Revenue< $1M

CellSource

CellSource (including company regionals)

cellsource.co.jp

See more website traffic and engagement information

Total visits to CellSource's top domains

Understand CellSource market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cellsource.co.jp12.4K

See more with Sales Intelligence

Avg. visit duration in CellSource's top domains

Analyze CellSource engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cellsource.co.jp00:01:16

See more with Sales Intelligence

Avg. pageviews on CellSource's top domains

See how CellSource keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cellsource.co.jp3.30

See more with Sales Intelligence

CellSource top competitors by domain

Top similar sites in February 2026, ranked by their affinity

silence-therapeutics.comCompany NameSilence TherapeuticsEmployees51 - 200HQUnited Kingdom, LondonAnnual revenue$15M - $25MTotal visits9.1KScience and Education > Biology

Top technologies used by CellSource

These are the website technologies, by industry, used by CellSource top domains

Advertising (11)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Widget (3)

reCAPTCHA

Content Management System (2)

WordPress

More Technologies

7

See all

News & Signals from CellSource

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTexchem Group partnered with CellSource Co., Ltd on Aug 8th '23.Petaling Jaya, 08 August 2023 - Malaysian conglomerate and Main Market-listed company Texchem Resources Bhd has entered into a letter of intent with CellSource Co Ltd to establish a joint venture (JV) to introduce CellSource's Platelet-derived Factor Concentrate Freeze Dry (PFC-FDTM) processing service, which is patented in Malaysia and Japan, to medical institutions in Malaysia.